Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Use this SCNI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SCNI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SCNI SEC filings page. Lician reads the product cache first so this HTML stays unique to Scinai Immunotherapeutics Ltd even when a live quote feed is slow.
Latest cached year on this hub. Full SCNI income, balance, and cash tables.